SetPoint Brings Bioelectronic Market to the Forefront with Study

June 12, 2018

“60% of patients in #SetPoint trial achieved significant reductions in their disease activity as assessed by the #Crohn‘s Disease Activity Index.” #BioelectronicMedicine zaps again!

SetPoint Medical has received positive data for its bioelectronic therapy for Crohn’s Disease.

Medical Device and Diagnostic Industry

#SetPointMedical #Device #CrohnsDisease #platform #Technology